Eculizumab bevarer de tidlige komponenter af komplementaktiveringen, der er essentiel for opsonisering af mikroorganismer og elimination af immunkomplekser.
Eculizumab preserves the early components of complement activation that are essential for opsonization of microorganisms and clearance of immune complexes.